Wells Fargo & Company Evogene Ltd. Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.75 - $1.33 $116 - $206	-155 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.09 - $1.83 $166 - $279	153 Added 7650.0%	155 $0
Q4 2021 Feb 14, 2022	SELL	$1.63 - $2.83 $4,715 - $8,187	-2,893 Reduced 99.93%	2 $0
Q3 2021 Nov 15, 2021	SELL	$2.45 - $3.45 $12,374 - $17,425	-5,051 Reduced 63.57%	2,895 $8,000
Q2 2021 Aug 16, 2021	BUY	$3.3 - $5.02 $16,321 - $24,828	4,946 Added 164.87%	7,946 $27,000
Q1 2021 May 13, 2021	SELL	$4.29 - $9.94 $136,061 - $315,257	-31,716 Reduced 91.36%	3,000 $15,000
Q4 2020 Feb 09, 2021	BUY	$2.41 - $5.63 $24,100 - $56,300	10,000 Added 40.46%	34,716 $163,000
Q3 2020 Nov 05, 2020	SELL	$0.97 - $4.08 $37,329 - $157,014	-38,484 Reduced 60.89%	24,716 $98,000
Q2 2020 Aug 13, 2020	BUY	$0.92 - $1.29 $42,504 - $59,598	46,200 Added 271.76%	63,200 $63,000
Q1 2020 May 14, 2020	BUY	$0.75 - $1.81 $12,750 - $30,770	17,000 New	17,000 $20,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $66.3M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.